The common cold, also known as upper respiratory tract infection (URI), is an acute, self-limited viral infection of the upper airway that may involve the lower respiratory tract as well. The characteristic symptom complex consisting of rhinorrhea, nasal congestion, and sore or scratchy throat is familiar to all adults. Colds are the most common cause of human illness and are responsible for significant absenteeism from school and work. Children are especially susceptible because: (1) they have not yet acquired immunity to many of the viruses; (2) they have poor personal hygiene practices; and (3) they have frequent close contact with other children who are excreting virus.

ETIOLOGY {#cesec1}
========

Colds are common because some of the causative viruses do not produce lasting immunity after infection and some viruses have numerous serotypes ([Table 28-1](#cetable1){ref-type="table"} ). Cold viruses that do not produce lasting immunity include respiratory syncytial virus (RSV), parainfluenza viruses, and coronaviruses. Cold viruses that have numerous serotypes but produce lasting serotype-specific immunity after infection include rhinoviruses, adenoviruses, influenza viruses, and enteroviruses.[@bib1] TABLE 28-1Immunity to Common Cold VirusesVirusNo of Serotypes**LONG-LASTING IMMUNITY NOT PRODUCED BY INFECTION (REPEATED INFECTION WITH SAME SEROTYPE USUAL)**Respiratory syncytial virus (RSV)1Parainfluenza virus4Coronavirus2**IMMUNITY PRODUCED BY INFECTION (REINFECTION WITH SAME SEROTYPE UNCOMMON)**Rhinovirus\> 100Adenovirus≥ 33Influenza3[a](#cetablefn1){ref-type="table-fn"}Echovirus31Coxsackievirus group A3Coxsackievirus group B6[^1]Modified from Hendley JO. Immunology of viral colds. In: Veldman JE, McCabe BF, Huizing EH, et al. (eds) Immunobiology, Autoimmunity, Transplantation in Otorhinolaryngology. Amsterdam, Kugler Publications, 1985, pp 257--260.© 20082008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

Rhinoviruses (*rhino,* nose), with at least 100 serotypes, are the most common cause of URIs in children and adults. At least 50% of colds in adults are caused by rhinovirus. Other viruses that cause URIs are coronaviruses (*corona,* crown), RSV, human metapneumovirus, influenza virus, parainfluenza virus, adenovirus, echoviruses, and coxsackieviruses A and B. Some of these viruses cause characteristic syndromes; for example, RSV causes bronchiolitis in children 2 years or younger, influenza viruses cause febrile respiratory illness with severe lower respiratory tract involvement, adenoviruses cause pharyngoconjunctival fever, parainfluenza viruses cause croup in young children, and enteroviruses cause a variety of illnesses, including aseptic meningitis and herpangina.

EPIDEMIOLOGY {#cesec2}
============

In temperate climates in the northern hemisphere, the predictable yearly epidemic of colds begins in September and continues unabated until spring. This sustained epidemic curve is a result of successive waves of different respiratory viruses moving through the community ([Figure 28-1](#f1){ref-type="fig"} ). The epidemic begins with a sharp rise in the frequency of rhinovirus infections in September (after children return to school), which is followed by parainfluenza viruses in October and November. RSV and coronaviruses circulate during the winter months, whereas infection due to influenza virus peaks in the late winter. The epidemic finally ends with a small resurgence of rhinovirus infections in the spring. Adenovirus infection occurs at a constant rate throughout the cold season.[@bib2] Figure 28-1Schematic diagram of the incidence of colds and frequency of causative viruses. RSV, respiratory syncytial virus.(Redrawn from Hendley JO. The common cold. In: Goldman L, Bennett JC (eds) Cecil Textbook of Medicine, 21st ed. Philadelphia, WB Saunders, 2000, pp 1790--1793.)

The frequency of colds varies with age. A 10-year study of families with children who did not attend a childcare facility showed that the peak incidence of colds occurs in preschool children 1 to 5 years old, with a frequency of 7.4 to 8.3 colds per year. Infants younger than 1 year averaged 6.7 colds per year, and teenagers averaged about 4.5 colds per year. Mothers and fathers experienced about 4 colds per year.[@bib3] With the greater exposure of children to other preschool children in childcare facilities, the frequency of colds in children younger than 6 years has increased. Thus, the typical preschool child experiences at least one URI per month throughout the cold season.

Viral transmission occurs primarily in the home setting, although the exact mechanism of spread has not been clearly established. Colds can be spread by: (1) small-particle (\<5 μm in diameter) aerosol, which infects when inhaled; or (2) large-particle (\>10 μm in diameter) droplets, which infect by landing on nasal or conjunctival mucosa; or (3) direct transfer via hand-to-hand contact.[@bib4] Small-particle aerosol is an effective method of transfer for influenza virus[@bib5] and coronavirus[@bib6] but not for RSV.[@bib7] Rhinoviruses are most likely spread by large-particle droplets or direct transfer. Rhinoviruses can survive as long as 2 hours on human hands and up to several days on other surfaces. Studies in young adults have shown that infected individuals commonly have rhinovirus on their hands, which can be efficiently transferred to the hands of uninfected individuals during brief contact; infection then results when the uninfected person transfers the virus from the hands on to his or her nasal or conjunctival mucosa. Sneezing and coughing are ineffective modes of rhinovirus transmission.[@bib8] Inoculation of the oral mucosa with rhinovirus[@bib9] or RSV[@bib10] does not result in infection.

PATHOGENESIS {#cesec3}
============

Symptoms of the common cold do not appear to result from destruction of nasal mucosa, because nasal biopsy specimens from young adults with both natural and experimentally induced colds show intact nasal epithelium during symptomatic illness.[@bib11] [@bib12] Study by in situ hybridization of nasal biopsy specimens obtained during rhinovirus infection indicates that replication occurs in only a small number of epithelial cells.[@bib13] [@bib14] Furthermore, in vitro studies have shown that rhinovirus and coronavirus produce no detectable cytopathic effect when replicating in a cultured monolayer of nasal epithelial cells, whereas influenza virus A and adenovirus produce obvious damage.[@bib15]

The symptoms of the common cold appear to result from release of cytokines and other mediators from infected nasal epithelial cells as well as from an influx of polymorphonuclear cells (PMNs). Nasal washings of volunteers experimentally infected with rhinovirus showed a 100-fold increase in PMN concentration 1 to 2 days after inoculation.[@bib16] This influx of PMNs coincides with onset of symptoms and correlates with the presence of a colored nasal discharge.[@bib17] A yellow or white nasal discharge may result from the higher number of PMNs, whereas the enzymatic activity of PMNs (due to myeloperoxidase and other enzymes) may cause a green nasal discharge. A potent chemoattractant for PMNs is produced by cells in culture infected with rhinovirus.[@bib18] This chemoattractant has been identified as interleukin 8 (IL-8).[@bib19] Elevated levels of IL-8 and other cytokines (IL-1β, IL-6) have also been demonstrated in the nasal secretions of infected individuals.[@bib20] [@bib21] Furthermore, elevated levels of albumin and kinins (predominantly bradykinin) in nasal secretions have been shown to coincide with the onset of symptoms in experimental rhinovirus infection.[@bib16] The elevated concentration of albumin and kinins likely results from exudation of plasma proteins due to greater vascular permeability in the nasal submucosa. The method by which viral infection initiates this vascular leak has not yet been determined. The release of kinins resulting from plasma exudation may augment the symptoms of the cold; bradykinin alone can cause rhinitis and sore throat when sprayed into the noses of uninfected individuals.[@bib22]

The paranasal sinuses are usually involved during an uncomplicated cold caused by respiratory viruses. In one study, computed tomographic (CT) scans obtained during the acute phase of illness revealed abnormalities of one or more sinuses in 27 (87%) of 31 young adults.[@bib23] Without antibiotic therapy, there was complete resolution or marked improvement of the sinus abnormalities in 11 (79%) of the 14 subjects in whom second CT scans were obtained 2 weeks later. It is not known whether these sinus abnormalities result from viral infection of the sinus mucosa or from impaired sinus drainage secondary to viral rhinitis. Nose-blowing can generate enough pressure to force fluid from the nasopharynx into the paranasal sinuses, suggesting that nose-blowing may force mucus containing viruses, bacteria, and inflammatory mediators into the paranasal sinuses during a cold.[@bib24]

The middle ear can also be involved during uncomplicated colds. Studies in school-aged children have shown that two-thirds will develop abnormal middle-ear pressures within 2 weeks after onset of a cold.[@bib25] Otitis media was not diagnosed during the study. It is not known whether the abnormal middle-ear pressures result from viral infection of the mucosa of the middle ear and eustachian tube or from viral nasopharyngitis with secondary eustachian tube dysfunction.

CLINICAL MANIFESTATIONS {#cesec4}
=======================

Symptoms of the common cold do not vary by specific cause. In older children and adults, rhinorrhea, nasal obstruction, and sore or scratchy throat are typical. The rhinorrhea is initially clear but may become colored as the illness proceeds. Cough or sneeze may be present. Fever (\>38°C) is uncommon in adults. Other symptoms are malaise, sinus fullness, and hoarseness. Objective findings are minimal except for mild erythema of the nasal mucosa or pharynx. Symptoms resolve in 5 to 7 days.

Compared with adults, infants and preschool children with colds are more likely to have fever (≥38°C) and moderate enlargement of the anterior cervical nodes ([Table 28-2](#cetable2){ref-type="table"} ).[@bib1] Rhinorrhea may not be noticed until the nasal discharge becomes colored. Nasal congestion may disrupt sleep and may lead to fatigue and irritability. The illness often persists in infants and preschool children for 10 to 14 days.[@bib26] TABLE 28-2Characteristics of Viral Colds in Adults and Young ChildrenCharacteristicAdultsChildren \< 6 yearsFrequency2--4 per yearOne per month, September--AprilFeverRareCommon during first 3 daysNasal manifestationsCongestionColored nasal dischargeDuration of illness5--7 days14 daysModified from Hendley JO. Epidemiology, pathogenesis, and treatment of the common cold. Semin Pediatr Infect Dis 1998;9:50--55.© 20082008Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company\'s public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

DIFFERENTIAL DIAGNOSIS {#cesec5}
======================

The differential diagnosis of a cold includes allergic rhinitis, vasomotor rhinitis, intranasal foreign body, and sinusitis. A diagnosis of allergic rhinitis is suggested by a seasonal pattern of clear rhinorrhea, absence of associated fever, and family history of allergy. Possible associated conditions are asthma and eczema. Physical findings consistent with allergic rhinitis include allergic "shiners" and "nasal salute." The detection of numerous eosinophils upon microscopic examination of the nasal mucus using Hansel stain confirms the diagnosis of allergic rhinitis. A diagnosis of vasomotor rhinitis is suggested by a chronic course without fever or sore throat. The diagnosis of bacterial sinusitis is suggested by persistent rhinorrhea or cough or both for greater than 10 days.[@bib27]

CLINICAL APPROACH {#cesec6}
=================

The diagnosis of a cold is based on history and physical examination; generally, laboratory tests are not useful. The rapid test for detecting RSV, influenza, parainfluenza, and adenovirus antigens in nasal secretions can be used to confirm the diagnosis. RSV, rhinovirus, influenza viruses, parainfluenza viruses, and adenoviruses can also be isolated in cell culture. Coronavirus cannot be detected reliably in cell culture, so serologic titer rise can be used for diagnosis, if necessary. Polymerase chain reaction assays for diagnosis of all the respiratory viruses are available in research laboratories and increasingly in clinical laboratories. Other methods of detection can be used but are rarely needed.

MANAGEMENT {#cesec7}
==========

At present, no antiviral agents are available that are effective for treatment of the common cold. Although an array of medications may be used to relieve symptoms, there is little scientific evidence to support the use of symptomatic treatments in children. Because the common cold is a self-limited illness with symptomatology that is largely subjective, a substantial placebo effect can suggest that various treatments have some efficacy. Inadequate blinding of placebo recipients in a study can make an ineffective treatment appear effective.

In adults with colds, first-generation antihistamines (i.e., chlorpheniramine) have been shown to provide modest symptomatic relief, with decreases in nasal discharge, sneezing, nose-blowing, and duration of symptoms.[@bib28] This effect is presumably due to the anticholinergic effects of these medications. A randomized, double-blind, placebo-controlled study in preschool children with URIs showed that treatment with an antihistamine--decongestant combination (brompheniramine maleate and phenylpropanolamine hydrochloride) produced no improvement in cough, rhinorrhea, or nasal congestion, although a larger proportion of the treated children (47% versus 26%) were asleep 2 hours after treatment.[@bib29]

Numerous decongestants, antitussives, and expectorants are available over the counter, but there is no evidence to support their use in children. A study of phenylephrine, a topical decongestant, in children 6 to 18 months old showed no decrease in nasal obstruction with its use during a URI.[@bib30] In a study comparing placebo, dextromethorphan, and codeine for cough suppression in children 18 months to 12 years old, cough decreased in all patients within 3 days, but there was no difference in cough reduction among the three treatment groups.[@bib31] Guaifenesin, an expectorant, has not been shown to change the volume or quality of sputum or the frequency of cough in young adults with colds.[@bib32] Echinacea preparations, commonly believed to be effective in the treatment of the common cold, have been shown to have no effect on the prevention or treatment of rhinovirus infection.[@bib33]

Antibiotics have no role in the treatment of uncomplicated URIs in children. Antibiotic therapy does not hasten resolution of the viral infection or reduce the likelihood of occurrence of secondary bacterial infection.[@bib34] Antibiotics are only indicated in cases of secondary bacterial infection, such as sinusitis and acute otitis media.

Thus, supportive measures remain the mainstay of treatment of the common cold in children. Bulb suction with saline drops (about 1 teaspoon salt in 2 cups of water) may help relieve nasal congestion and remove secretions.

COMPLICATIONS {#cesec8}
=============

The common cold usually resolves in about 10 to 14 days in infants and children. New-onset fever and earache during this period may herald the development of bacterial otitis media, which occurs in about 5% of colds in preschool children. Persistence of nasal symptoms for longer than 10 days may signify the development of a secondary bacterial sinusitis. Bacterial pneumonia is an uncommon secondary infection. For children with underlying reactive airways disease, wheezing is common during the course of a viral URI; at least 50% of asthma exacerbations in children are associated with viral infection. Children who experience more than one lower respiratory tract infection (such as croup or bronchiolitis) during their first year of life have an increased risk of asthma thereafter.[@bib35] Other complications are epistaxis, eustachian tube dysfunction, conjunctivitis, and pharyngitis.

RECENT ADVANCES {#cesec9}
===============

Research now suggests that the symptoms of the common cold result from effects of inflammatory mediators released in response to the viral infection of the respiratory tract. As the determinants of this process are further elucidated, treatments may be developed that can interrupt or ameliorate release of inflammatory mediators and thus prevent or reduce the symptoms of the common cold. Vaccines are unlikely to be useful for prevention, given the large number of serotypes of some cold viruses as well as the lack of lasting immunity to others. The use of alcohol-based hand gels has been suggested as a means of reducing secondary transmission of respiratory illnesses in the home,[@bib36] but in one field trial, this was not shown to be effective.[@bib37] Also, virucidal tissues have been shown to be effective in preventing viral passage and transmission, and may reduce secondary transmission by about 30%.[@bib38] [@bib39] Until new methods are developed, prevention of the common cold is limited to avoiding self-inoculation (transfer of virus from contaminated fingers to nasal or conjunctival mucosa) by removing virus through handwashing or by killing virus with application of a virucide to the hands.

[^1]: Type A subtypes change.
